Saito Yuichi, Kitahara Hideki, Shoji Toshihiro, Tokimasa Satoshi, Nakayama Takashi, Sugimoto Kazumasa, Fujimoto Yoshihide, Kobayashi Yoshio
Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.
Heart Vessels. 2018 Aug;33(8):846-852. doi: 10.1007/s00380-018-1139-z. Epub 2018 Feb 12.
Intracoronary acetylcholine (ACh) provocation test is useful to diagnose vasospastic angina. Although outpatient coronary angiography has been widely performed in current clinical settings, the feasibility and safety of ACh provocation test in outpatient services are unclear. A total of 323 patients, who electively underwent ACh provocation test in hospitalization and outpatient services, were included. Coronary angiography was performed after insertion of a temporary pacing electrode in the right ventricle. The positive diagnosis of intracoronary ACh provocation test was defined as total or subtotal coronary artery narrowing accompanied by chest pain and/or ischemic electrocardiographic changes. Cardiac complications defined as composite of death, ventricular fibrillation or sustained ventricular tachycardia, myocardial infarction, cardiogenic shock, and cardiac tamponade, were evaluated. There were 201 patients (62%) in the hospitalization group and 122 patients (38%) in the outpatient group. The incidence of positive ACh provocation test was similar between the 2 groups (47 vs. 54%, p = 0.21). Coronary angiography in the outpatient group was performed through the radial artery, mostly (98%) with a 4 F sheath. Venous access site was not significantly different between the 2 groups, and the sheath size was 5 F in all cases. There were 2 cases (1.0%) of cardiac complications in the hospitalization group, whereas 1 case (0.8%), which led to unexpected hospitalization, occurred in the outpatient group. In conclusion, intracoronary ACh provocation test for the diagnosis of vasospastic angina in outpatient services was feasible and safe in selected patients.
冠状动脉内乙酰胆碱(ACh)激发试验有助于诊断血管痉挛性心绞痛。尽管门诊冠状动脉造影在当前临床环境中已广泛开展,但ACh激发试验在门诊服务中的可行性和安全性尚不清楚。本研究共纳入323例在住院和门诊接受选择性ACh激发试验的患者。在右心室插入临时起搏电极后进行冠状动脉造影。冠状动脉内ACh激发试验的阳性诊断定义为冠状动脉完全或次全狭窄,并伴有胸痛和/或缺血性心电图改变。评估的心脏并发症定义为死亡、心室颤动或持续性室性心动过速、心肌梗死、心源性休克和心脏压塞的综合情况。住院组有201例患者(62%),门诊组有122例患者(38%)。两组ACh激发试验阳性发生率相似(47%对54%,p = 0.21)。门诊组冠状动脉造影大多通过桡动脉进行(98%),使用4F鞘管。两组静脉穿刺部位无显著差异,所有病例鞘管大小均为5F。住院组有2例(1.0%)发生心脏并发症,而门诊组有1例(0.8%)发生心脏并发症并导致意外住院。总之,在门诊服务中,对选定患者进行冠状动脉内ACh激发试验以诊断血管痉挛性心绞痛是可行且安全的。